First National Trust’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.85M | Buy |
23,176
+135
| +0.6% | +$40.1K | 0.23% | 97 |
|
|
2025
Q4 | $6.29M | Buy |
23,041
+193
| +0.8% | +$52.4K | 0.21% | 101 |
|
|
2025
Q3 | $6.17M | Sell |
22,848
-216
| -0.9% | -$58.8K | 0.21% | 103 |
|
|
2025
Q2 | $6.36M | Buy |
23,064
+302
| +1% | +$82.1K | 0.24% | 99 |
|
|
2025
Q1 | $6.04M | Sell |
22,762
-22
| -0.1% | -$5.43K | 0.24% | 98 |
|
|
2024
Q4 | $5.29M | Buy |
22,784
+1,311
| +6% | +$301K | 0.2% | 106 |
|
|
2024
Q3 | $4.74M | Sell |
21,473
-684
| -3% | -$142K | 0.18% | 113 |
|
|
2024
Q2 | $4.36M | Sell |
22,157
-276
| -1% | -$57K | 0.18% | 110 |
|
|
2024
Q1 | $4.83M | Sell |
22,433
-1,057
| -4% | -$222K | 0.2% | 111 |
|
|
2023
Q4 | $4.95M | Sell |
23,490
-2,152
| -8% | -$459K | 0.22% | 99 |
|
|
2023
Q3 | $5.13M | Buy |
25,642
+331
| +1% | +$65.8K | 0.25% | 98 |
|
|
2023
Q2 | $4.69M | Buy |
25,311
+3,935
| +18% | +$727K | 0.22% | 107 |
|
|
2023
Q1 | $4.09M | Buy |
21,376
+1,002
| +5% | +$181K | 0.22% | 108 |
|
|
2022
Q4 | $3.43M | Sell |
20,374
-300
| -1% | -$52.1K | 0.18% | 116 |
|
|
2022
Q3 | $3.66M | Sell |
20,674
-597
| -3% | -$118K | 0.21% | 108 |
|
|
2022
Q2 | $4.35M | Buy |
21,271
+182
| +0.9% | +$38.6K | 0.25% | 99 |
|
|
2022
Q1 | $5.02M | Buy |
21,089
+391
| +2% | +$91.8K | 0.26% | 101 |
|
|
2021
Q4 | $4.73M | Sell |
20,698
-671
| -3% | -$148K | 0.25% | 107 |
|
|
2021
Q3 | $4.13M | Sell |
21,369
-1,462
| -6% | -$296K | 0.25% | 104 |
|
|
2021
Q2 | $4.86M | Sell |
22,831
-1,092
| -5% | -$231K | 0.3% | 95 |
|
|
2021
Q1 | $4.89M | Sell |
23,923
-2,920
| -11% | -$575K | 0.32% | 88 |
|
|
2020
Q4 | $4.89M | Sell |
26,843
-2,040
| -7% | -$347K | 0.34% | 86 |
|
|
2020
Q3 | $4.83M | Sell |
28,883
-2,983
| -9% | -$502K | 0.38% | 78 |
|
|
2020
Q2 | $5.18M | Sell |
31,866
-2,252
| -7% | -$404K | 0.44% | 68 |
|
|
2020
Q1 | $5.9M | Sell |
34,118
-5,758
| -14% | -$1.15M | 0.59% | 56 |
|
|
2019
Q4 | $8M | Buy |
39,876
+2,976
| +8% | +$611K | 0.65% | 48 |
|
|
2019
Q3 | $7.8M | Buy |
36,900
+3,558
| +11% | +$743K | 0.7% | 42 |
|
|
2019
Q2 | $6.47M | Buy |
33,342
+2,427
| +8% | +$447K | 0.6% | 49 |
|
|
2019
Q1 | $5.09M | Buy |
30,915
+2,212
| +8% | +$391K | 0.51% | 61 |
|
|
2018
Q4 | $5.4M | Buy |
28,703
+1,886
| +7% | +$348K | 0.6% | 53 |
|
|
2018
Q3 | $4.56M | Buy |
26,817
+1,914
| +8% | +$322K | 0.46% | 63 |
|
|
2018
Q2 | $4.08M | Buy |
24,903
+1,587
| +7% | +$259K | 0.45% | 65 |
|
|
2018
Q1 | $3.77M | Buy |
23,316
+4,556
| +24% | +$725K | 0.43% | 75 |
|
|
2017
Q4 | $2.74M | Buy |
18,760
+2,061
| +12% | +$294K | 0.3% | 97 |
|
|
2017
Q3 | $2.27M | Buy |
16,699
+2,990
| +22% | +$378K | 0.26% | 108 |
|
|
2017
Q2 | $1.72M | Buy |
13,709
+4,056
| +42% | +$485K | 0.21% | 129 |
|
|
2017
Q1 | $1.15M | Buy |
+9,653
| New | +$1.16M | 0.15% | 153 |
|
Other funds holding CME
VCM
VPM
First National Trust's CME Position: Q1 2026 in Review
First National Trust increased its CME Group (CME) stake by 0.59% in Q1 2026, buying an estimated $40.1K and bringing the position to 23,176 shares worth $6.85M. The position accounts for 0.23% of the portfolio, ranked #97.
First National Trust first reported a position in CME in Q1 2017 and has held it in 37 quarters since. The position peaked at $8M in Q4 2019. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- First National Trust held 23,176 shares of CME Group worth $6.85M as of Q1 2026.
- First National Trust bought 135 CME Group shares in Q1 2026, an estimated $40.1K.
- CME Group made up 0.23% of First National Trust's portfolio in Q1 2026, its #97 holding.
- First National Trust first reported a position in CME Group in Q1 2017 and has held it in 37 quarters since.
- First National Trust's CME Group position peaked at $8M in Q4 2019.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on First National Trust's 13F filing for Q1 2026, filed 7 May 2026.